HomeCompareARVY vs MRK

ARVY vs MRK: Dividend Comparison 2026

ARVY yields 66889.63% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ARVY wins by $8.727817201939636e+24M in total portfolio value
10 years
ARVY
ARVY
● Live price
66889.63%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.727817201939636e+24M
Annual income
$8,702,224,904,608,491,000,000,000,000,000.00
Full ARVY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ARVY vs MRK

📍 ARVY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodARVYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ARVY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ARVY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARVY
Annual income on $10K today (after 15% tax)
$5,685,618.73/yr
After 10yr DRIP, annual income (after tax)
$7,396,891,168,917,217,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ARVY beats the other by $7,396,891,168,917,217,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARVY + MRK for your $10,000?

ARVY: 50%MRK: 50%
100% MRK50/50100% ARVY
Portfolio after 10yr
$4.363908600969818e+24M
Annual income
$4,351,112,452,304,246,000,000,000,000,000.00/yr
Blended yield
99.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ARVY
No analyst data
Altman Z
-4.1
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARVY buys
0
MRK buys
0
No recent congressional trades found for ARVY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricARVYMRK
Forward yield66889.63%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$8.727817201939636e+24M$56.8K
Annual income after 10y$8,702,224,904,608,491,000,000,000,000,000.00$9,798.13
Total dividends collected$8.726138640334245e+24M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ARVY vs MRK ($10,000, DRIP)

YearARVY PortfolioARVY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$6,699,663$6,688,963.21$11,206$366.19+$6.69MARVY
2$4,195,374,316$4,188,205,676.68$12,650$502.35+$4195.36MARVY
3$2,455,594,339,798$2,451,105,289,279.80$14,407$694.19+$2455594.33MARVY
4$1,343,427,784,326,536$1,340,800,298,382,952.00$16,585$967.82+$1343427784.31MARVY
5$686,985,711,471,255,800$685,548,243,742,026,400.00$19,342$1,363.89+$686985711471.24MARVY
6$328,368,063,194,057,000,000$327,632,988,482,782,760,000.00$22,913$1,947.19+$328368063194057.00MARVY
7$146,709,551,459,088,530,000,000$146,358,197,631,470,890,000,000.00$27,662$2,823.89+$146709551459088512.00MARVY
8$61,269,578,085,045,490,000,000,000$61,112,598,864,984,270,000,000,000.00$34,159$4,173.35+$61269578085045485568.00MARVY
9$23,918,034,888,922,243,000,000,000,000$23,852,476,440,371,242,000,000,000,000.00$43,337$6,308.80+$2.391803488892224e+22MARVY
10$8,727,817,201,939,636,000,000,000,000,000$8,702,224,904,608,491,000,000,000,000,000.00$56,776$9,798.13+$8.727817201939636e+24MARVY

ARVY vs MRK: Complete Analysis 2026

ARVYStock

Alliance Recovery Corporation, a development stage company, develops resource recovery technologies to convert industrial and other waste materials into fuel oil, gases, and other commodities. It focuses on converting industrial and other waste materials into electrical energy for sale to industrial entities or into local power grids, and to produce for re-sale by-products, including carbon black, steel, and steam and/or hot water. The company was formerly known as American Resource Recovery Group, Ltd. and changed its name to Alliance Recovery Corporation in 2002. Alliance Recovery Corporation was incorporated in 2001 and is based in Wilmington, Delaware.

Full ARVY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ARVY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARVY vs SCHDARVY vs JEPIARVY vs OARVY vs KOARVY vs MAINARVY vs JNJARVY vs ABBVARVY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.